MediWound Ltd. (MDWD)
NASDAQ: MDWD · IEX Real-Time Price · USD
17.59
+1.18 (7.19%)
At close: Apr 24, 2024, 4:00 PM
17.47
-0.12 (-0.68%)
After-hours: Apr 24, 2024, 5:05 PM EDT
MediWound Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MediWound stock have an average target of 32, with a low estimate of 28 and a high estimate of 36. The average target predicts an increase of 81.92% from the current stock price of 17.59.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 22, 2024.
Analyst Ratings
The average analyst rating for MediWound stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +59.18% | Mar 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $26 → $28 | Strong Buy | Maintains | $26 → $28 | +59.18% | Jan 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +47.81% | Nov 22, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 → $26 | Strong Buy | Maintains | $23 → $26 | +47.81% | Sep 21, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $63 → $36 | Buy | Maintains | $63 → $36 | +104.66% | Aug 17, 2023 |
Financial Forecast
Revenue This Year
24.52M
from 18.69M
Increased by 31.23%
Revenue Next Year
32.58M
from 24.52M
Increased by 32.86%
EPS This Year
-1.97
from -0.75
EPS Next Year
-1.90
from -1.97
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 25.7M | 35.8M | 65.3M | 103.0M | 155.7M |
| Avg | 24.5M | 32.6M | 55.1M | 98.3M | 141.6M |
| Low | 23.2M | 29.4M | 44.9M | 92.8M | 126.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 37.4% | 46.1% | 100.4% | 87.1% | 58.3% |
| Avg | 31.2% | 32.9% | 69.0% | 78.6% | 44.0% |
| Low | 24.2% | 19.9% | 37.7% | 68.6% | 29.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.79 | -1.55 | 0.37 | 1.28 | 2.35 |
| Avg | -1.97 | -1.90 | 0.15 | 1.24 | 2.28 |
| Low | -2.06 | -2.06 | -0.06 | 1.20 | 2.20 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 766.1% | 89.0% |
| Avg | - | - | - | 741.4% | 83.6% |
| Low | - | - | - | 708.4% | 76.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.